Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress
TARGET-1 and TARGET-2 trials: safe decongestion using first fully automated fluid management system
Biology
Sat, 25/05/2019 - 06:30
Thu, 23/05/2019 - 07:00
The completion of series B fundraise of £10.3 million
The appointment of Paul Atherton as Chairman
COMPLETION OF SERIES B FUNDRAISE
Tue, 21/05/2019 - 15:15
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovat
Tue, 21/05/2019 - 07:00
London, UK, 21st May 2019 / Sciad Newswire / The £27m UK Innovation & Science Seed Fund (UKI2S) and In
Thu, 25/04/2019 - 07:00
Bournemouth, UK, and Fordingbridge, UK, 25th April 2019 / Sciad Newswire / Solentim, the
Thu, 21/03/2019 - 10:31
London, UK, 21st March 2019 / Sciad Newswire / Inspired by the success of Pharma Integrates, Life Science Integra
Tue, 05/03/2019 - 07:30
Stevenage, UK, 5th March 2019 / Sciad Newswire / Procarta Biosystems, a privately held UK-based biotec
Thu, 21/02/2019 - 07:00
Dublin, Ireland and Bournemouth, UK, 21st February 2019 / Sciad Newswire / Valitacell, a biotechnology company transformin
Wed, 06/02/2019 - 07:30
London, UK, 6th February 2019 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, announced
Mon, 14/01/2019 - 07:30
Bournemouth, UK and Newark, CA, USA, 14th January 2019 / Sciad Newswire / Solentim, a global leader in cell line developmen